Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yohei Sekino is a pioneering urologic surgeon and researcher at the forefront of robotic surgery in Japan. His work centers on advancing minimally invasive techniques for urologic oncology and benign prostatic hyperplasia (BPH), with a particular focus on evaluating novel robotic platforms. Dr. Sekino has been instrumental in assessing the real-world safety and effectiveness of the hinotori™ Surgical Robot System for tumor surgeries, including robot-assisted radical prostatectomy (RARP) and partial nephrectomy. He has also explored the AQUABEAM Robotic System for Aquablation therapy in Japanese BPH patients, contributing critical data on its efficacy and patient-reported outcomes. With over 20 citations across his most-cited works, his research provides key insights into postoperative outcomes, such as identifying predictors of long-term urinary incontinence after RARP and demonstrating that high preoperative testosterone levels can predict preserved sexual function following nerve-sparing procedures. His comparative studies on robotic versus laparoscopic adrenalectomy are shaping surgical standards in Japan. Dr. Sekino’s work is vital for surgeons adopting next-generation robotic technologies and for improving quality-of-life outcomes in urologic cancer patients.